年単位の研究成果
Fingerprint Eiji Iwamaが取り組む研究トピックをご確認ください。これらのトピックラベルは、この人物の研究に基づいています。これらを共に使用することで、固有の認識が可能になります。
- 14 同様のプロファイル
Non-Small Cell Lung Carcinoma
Medicine & Life Sciences
Protein-Tyrosine Kinases
Medicine & Life Sciences
Epidermal Growth Factor Receptor
Medicine & Life Sciences
Mutation
Medicine & Life Sciences
Pemetrexed
Medicine & Life Sciences
erbB-1 Genes
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
ネットワーク
最近の共同研究。丸をクリックして詳細を確認しましょう。
研究成果 2011 2019
Genetic Profiling of Non-Small Cell Lung Cancer at Development of Resistance to First- or Second-Generation EGFR-TKIs by CAPP-Seq Analysis of Circulating Tumor DNA
Otsubo, K., Sakai, K., Takeshita, M., Harada, D., Azuma, K., Ota, K., Akamatsu, H., Goto, K., Horiike, A., Kurata, T., Nakagaki, N., Nosaki, K., Iwama, E., Nakanishi, Y., Nishio, K. & Okamoto, I., 1 1 2019, ： : Oncologist. 24, 8, p. 1022-1026 5 p.研究成果: ジャーナルへの寄稿 › 記事
High-Throughput Nucleotide Sequencing
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
DNA
Identification of genomic alterations acquired during treatment with EGFR-TKIs in non-small cell lung cancer
Kubo, N., Harada, T., Shiraishi, Y., Nosaki, K., Nakagaki, N., Takeshita, M., Ouchi, H., Iwama, E., Tanaka, K., Okamoto, I., Sasaki, H. & Nakanishi, Y., 2 2019, ： : Anticancer research. 39, 2, p. 671-677 7 p.研究成果: ジャーナルへの寄稿 › 記事
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Therapeutics
Exome
Immune checkpoint protein and cytokine expression by T lymphocytes in pleural effusion of cancer patients receiving anti–PD-1 therapy
Ikematsu, Y., Tanaka, K., Yanagihara, T., Liu, R., Inoue, H., Yoneshima, Y., Ota, K., Iwama, E., Takata, S., Hata, K., Takahata, Y., Wataya, H., Nakanishi, Y. & Okamoto, I., 12 2019, ： : Lung Cancer. 138, p. 58-64 7 p.研究成果: ジャーナルへの寄稿 › 記事
Pleural Effusion
Cytokines
T-Lymphocytes
Cell- and Tissue-Based Therapy
Neoplasms
1
引用
(Scopus)
Longitudinal monitoring of somatic genetic alterations in circulating cell-free DNA during treatment with epidermal growth factor receptor–tyrosine kinase inhibitors
Iwama, E., Sakai, K., Hidaka, N., Inoue, K., Fujii, A., Nakagaki, N., Ota, K., Toyozawa, R., Azuma, K., Nakatomi, K., Harada, T., Hisasue, J., Sakata, S., Shimose, T., Kishimoto, J., Nakanishi, Y., Nishio, K. & Okamoto, I., 1 1 2019, (受理済み/印刷中) ： : Cancer.研究成果: ジャーナルへの寄稿 › 記事
Epidermal Growth Factor Receptor
Epidermal Growth Factor
Phosphotransferases
DNA
Protein-Tyrosine Kinases
2
引用
(Scopus)
Safety and efficacy of PD-1 inhibitors in non–small cell lung cancer patients positive for antinuclear antibodies
Yoneshima, Y., Tanaka, K., Shiraishi, Y., Hata, K., Watanabe, H., Harada, T., Otsubo, K., Iwama, E., Inoue, H., Masuda, S., Nakanishi, Y. & Okamoto, I., 4 2019, ： : Lung Cancer. 130, p. 5-9 5 p.研究成果: ジャーナルへの寄稿 › 記事
Antinuclear Antibodies
Non-Small Cell Lung Carcinoma
Safety
Autoimmune Diseases
Disease-Free Survival